Exelixis Inc (EXEL)
35.62
+0.80
(+2.28%)
USD |
NASDAQ |
Nov 22, 12:34
Exelixis Total Assets (Quarterly): 2.960B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 2.960B |
| June 30, 2024 | 2.773B |
| March 31, 2024 | 2.804B |
| December 31, 2023 | 2.942B |
| September 30, 2023 | 2.977B |
| June 30, 2023 | 3.142B |
| March 31, 2023 | 3.143B |
| December 31, 2022 | 3.071B |
| September 30, 2022 | 2.961B |
| June 30, 2022 | 2.881B |
| March 31, 2022 | 2.654B |
| December 31, 2021 | 2.616B |
| September 30, 2021 | 2.448B |
| June 30, 2021 | 2.367B |
| March 31, 2021 | 2.191B |
| December 31, 2020 | 2.137B |
| September 30, 2020 | 2.111B |
| June 30, 2020 | 2.047B |
| March 31, 2020 | 1.956B |
| December 31, 2019 | 1.886B |
| September 30, 2019 | 1.785B |
| June 30, 2019 | 1.643B |
| March 31, 2019 | 1.542B |
| December 31, 2018 | 1.422B |
| September 30, 2018 | 1.024B |
| Date | Value |
|---|---|
| June 30, 2018 | 911.16M |
| March 31, 2018 | 774.92M |
| December 31, 2017 | 655.29M |
| September 30, 2017 | 609.77M |
| June 30, 2017 | 516.53M |
| March 31, 2017 | 586.98M |
| December 31, 2016 | 595.74M |
| September 30, 2016 | 548.49M |
| June 30, 2016 | 477.14M |
| March 31, 2016 | 492.53M |
| December 31, 2015 | 332.34M |
| September 30, 2015 | 363.24M |
| June 30, 2015 | 248.78M |
| March 31, 2015 | 282.93M |
| December 31, 2014 | 323.27M |
| September 30, 2014 | 383.66M |
| June 30, 2014 | 440.64M |
| March 31, 2014 | 497.56M |
| December 31, 2013 | 503.29M |
| September 30, 2013 | 555.96M |
| June 30, 2013 | 612.08M |
| March 31, 2013 | 659.53M |
| December 31, 2012 | 721.10M |
| September 30, 2012 | 762.61M |
| June 30, 2012 | 374.49M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.886B
Minimum
Dec 2019
3.143B
Maximum
Mar 2023
2.603B
Average
2.714B
Median
Total Assets (Quarterly) Benchmarks
| Merck & Co Inc | 117.53B |
| ADMA Biologics Inc | 390.62M |
| Vericel Corp | 390.40M |
| Catalyst Pharmaceuticals Inc | 772.01M |
| Inovio Pharmaceuticals Inc | 107.06M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 684.86M |
| Shareholders Equity (Quarterly) | 2.275B |
| Current Ratio | 3.930 |